Bipoláris betegek lamotrigin kezelése - relapszus ráta és szuicid magatartás 6 hónapos követés során

The present paper describes a 8-month prospective, observational, non-intervention multicentric study in 969 bipolar patients, where data were obtained on changes during lamotrigine treatment with special focus rates of relapse, suicidal behaviour and adverse events. 969 patients entered the study a...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Rihmer Zoltán
Gonda Xénia
Kálmán János
Dokumentumtípus: Cikk
Megjelent: 2015
Sorozat:NEUROPSYCHOPHARMACOLOGIA HUNGARICA 17 No. 1
mtmt:2919586
Online Access:http://publicatio.bibl.u-szeged.hu/14083
LEADER 01782nab a2200217 i 4500
001 publ14083
005 20181126142010.0
008 181126s2015 hu o 0|| zxx d
022 |a 1419-8711 
024 7 |a 2919586  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Rihmer Zoltán 
245 1 0 |a Bipoláris betegek lamotrigin kezelése - relapszus ráta és szuicid magatartás 6 hónapos követés során  |h [elektronikus dokumentum] /  |c  Rihmer Zoltán 
260 |c 2015 
300 |a 7-13 
490 0 |a NEUROPSYCHOPHARMACOLOGIA HUNGARICA  |v 17 No. 1 
520 3 |a The present paper describes a 8-month prospective, observational, non-intervention multicentric study in 969 bipolar patients, where data were obtained on changes during lamotrigine treatment with special focus rates of relapse, suicidal behaviour and adverse events. 969 patients entered the study and 961 patients (99%) completed the study. Patients received lamotrigine mostly as an add-on treatment in addition to ongoing antidepressant and/or antipsychotic medication. By the end of the six-month treatment period 38% of patients achieved remission and rate of relapse after three months was 24%. Rate of adverse events was very low (1%) and they in no case led o termination of therapy. At baseline 17% of patients had clinically significant suicide risk which gradually decreased to 2.1% during the 6-month study period. No suicide attempt or completed suicide occurred during the study period. Results indicate that lamotrigine is an effective and well-tolerated treatment for the acute and long-term treatment of bipolar patients. 
700 0 1 |a Gonda Xénia  |e aut 
700 0 1 |a Kálmán János  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/14083/1/rihmer.pdf  |z Dokumentum-elérés